A Phase 1b/2, Randomized, Open-Label Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine as Maintenance Therapy in Patients With Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer

  • Frentzas, Sophia (Primary Chief Investigator (PCI))
  • Strickland, Andrew (Chief Investigator (CI))

Project: Research

Project Details

StatusActive
Effective start/end date20/10/22 → 19/10/27